Objective: Virtual-assisted lung mapping is a preoperative bronchoscopic multi-spot dye-marking technique. This study aimed to examine the efficacy of virtual-assisted lung mapping for obtaining sufficient surgical margins in sublobar lung resection.
indication and required safe margin for lung cancer and metastatic lung tumors remain controversial. 1, 2 Virtual-assisted lung mapping (VAL-MAP) is a relatively novel, bronchoscopic, preoperative, multi-spot dye marking technique that uses virtual images (eg, virtual bronchoscopy) to assist in identifying lesions intraoperatively (Video 1). 3 VAL-MAP was originally developed in Japan to overcome the limitations of CT-guided percutaneous needle-mediated marking techniques, especially the hookwire method, wherein potentially fatal air embolism was reported in 1% to 2% of cases. [4] [5] [6] [7] [8] VAL-MAP is reportedly safe, with no reported cases of air embolism and limited complications even after the accumulation of 500 cases in a multicenter trial. 9 In addition to localization of small nodules, the multiple marks function as reference points of the ''lung map'' on the lung surface. The lung map assists surgeons to determine appropriate resection lines in wedge resections and segmentectomies, especially in extended or complex segmentectomies, [10] [11] [12] although it is not mandatory to place marks on resection lines. However, a previous multicenter prospective study in Japan showing a successful resection rate of 99% did not take surgical margins into consideration. 10 Acquisition of resection margins is critical in limited lung resections. Insufficient resection margins in limited resections are reportedly associated with a greater incidence of local regional recurrence [13] [14] [15] [16] and are potentially associated with poorer clinical outcomes. 17 Beyond the concept of tumor localization in conventional marking techniques, VAL-MAP has the potential to design limited lung resection surgery that guarantees sufficient resection margins.
We hypothesized that VAL-MAP would enable efficient determination of satisfactory resection lines. The primary purpose of the present study was to rigorously examine the impact of VAL-MAP on resection margins in thoracoscopic lung resection.
MATERIALS AND METHODS
A multicenter, prospective, single-arm study was conducted from September 2016 to July 2017 under the supervision of the Japanese Ministry of Health, Labour, and Welfare to evaluate the safety and efficacy of VAL-MAP. The study protocol is shown in the Online Data Supplement.
Patient Registration
Patients meeting the inclusion and exclusion criteria described in Table E1 were enrolled after providing informed consent. Briefly, patients with pulmonary nodule or nodules that showed the following characteristics were enrolled: suspected or diagnosed as malignant, requiring sublobar lung resection (ie, wedge resection or segmentectomy) for curative treatment, and anticipated to require careful determination of resection lines to ensure resection margins because of difficult intraoperative tumor localization (eg, due to a GGO component, diameter 5 mm, or diameter equal to or less than the distance from the visceral pleura). A present or past medical history of bronchial asthma was considered a relative contraindication, and if the risk was assessed as greater than the potential benefit to the patient, he or she was excluded from the study as per exclusion criterion III. Otherwise, a bronchodilator was used prophylactically following the bronchoscopic guidelines issued by the safety committee of the Japan Society for Respiratory Endoscopy 18 and the guidelines issued by the British Thoracic Society. 19 
Mapping Procedure
The mapping procedure was conducted on the day of surgery, or 1 or 2 days preoperatively, on the basis of the data obtained in a previous clinical trial. 10 The multiple spots on the lung surface or lung map were designed on the basis of CT images and corresponding virtual bronchoscopy, and the target bronchi were identified. The workstation used for this process was not specified, but was dependent on the preferences of each center. The details of the bronchoscopic marking technique have been described. 3, 8, 9 In short, under sedation and local anesthesia, thoracic surgeons or respirologists conducted the bronchoscopic procedure while monitoring blood pressure, electrocardiography, and oxygenation. The bronchoscope (BF-260F or BF-P260F; Olympus, Tokyo, Japan) was orally inserted. Once the target bronchi were identified using prepared virtual bronchoscopy as guidance, a metal blunt-tip catheter (P6-CW-1, Olympus) preloaded with 1 mL of indigo carmine was gently inserted through the working channel of the bronchoscope into each target bronchus and then injected 
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under fluoroscopic confirmation. After awakening the patient, another CT scan was performed to localize the actual markings to adjust for possible dislocation from the original plan, as reported previously. 20 The CT images were reconstructed into 3 dimensions. Because injected indigo carmine remains visible in the lung for up to 2 days, 10 surgery was conducted on the same day as marking or 1 or 2 days after depending on the logistics (see Video 1 for the details of the technique). The patients were followed for 30 days after the planned day of surgery. When an adverse event was detected, the affected patients were followed for more than 30 days.
End Points
The primary end point was successful resection, which was defined as resection of the lesion with resection margins larger than or equal to the lesion diameter or 2 cm using the initial planned resection. The resection was considered unsuccessful if the resection margins measured intraoperatively were insufficient and additional resection was conducted. The resection was considered unsuccessful regardless of the resection margins if insufficient lung mapping or insufficient localization of the lesion necessitated changes in the operation plan (eg, conversion from wedge resection to segmentectomy) or approach (eg, conversion from video-assisted thoracic surgery to open thoracotomy for palpation). In patients in whom the success of the resection could not be simply judged on the basis of the electronic case reporting form, an objective judgment was made by the event evaluation committee composed of a third party.
Resection margins were measured macroscopically by the surgeon intraoperatively while the lung was deflated. The registered lesion diameter measured by preoperative CT was used for the calculation. If the lesion was not identified macroscopically, and microscopic or pathologic examination revealed a compatible lesion, the lesion was considered successfully resected and the margin was measured in the pathology department, taking the width of the stapler into consideration.
We defined the primary goal of the study as the verification of a success proportion of not less than 90% and the achievement of successful resection in 95% of cases (lower limit of confidence interval [CI], 90%) based on our retrospective data analysis of resection margins at the University of Tokyo that compared VAL-MAP, CT-guided marking, and no marking. 21 The details are described in the study protocol (Online Data Supplement). The number of lesions required was calculated as 210 with the 1-sided significance level set at 2.5% and statistical power set at approximately 75% by which the lower threshold of 95% CI based on binomial distribution was higher than 90%. In a previous study, each patient had an average of 1.35 lesions 10 ; thus, an enrollment of 160 patients was expected to yield 210 lesions for analysis in the present study.
Secondary end points were (1) effectiveness of lung marking, (2) effectiveness of VAL-MAP-assisted surgery, and (3) safety. To evaluate the effectiveness of lung marking, the number of markings identified intraoperatively and the number of conducted markings were calculated. Successful localization of the lesion was evaluated regarding the whole lung map (combination of multiple markings). The effectiveness of surgery was evaluated as the effectiveness of the surgical approach (thoracoscopy alone vs palpation via a small thoracotomy) and resection method (wedge resection alone vs enlarged resection). The contribution degree of the marking to surgery was evaluated by the surgeon. Operation time was recorded. In regard to safety, data were collected on adverse events that occurred during and after the bronchoscopic procedure, and before, during, and after surgery up to postoperative day 30.
Data Collection and Analysis
All data were collected using electronic data recorded at each institution. All data analyses were conducted independently by specialized statisticians according to the study protocol. The data were expressed as mean AE standard deviation and median (min-max) when appropriate. Success rate of resection was assessed, and the 95% CI was calculated using the exact method. Also, potential risk factors assumed to affect resection failure were assessed using multivariable risk ratio regression model, including required resection depth, planned operation, measurement of resection margin on regular basis in the center, surgeons' average experience in thoracic surgery, and lesion characteristics as explanatory variables. To examine the more detailed relationship between the required resection depth and the resection failure/success, restricted cubic spline model was used, adjusting for the potential risk factors described. All reported P values were 2-tailed. Statistical analyses were performed using SAS9.4 software (SAS Institute Inc, Cary, NC).
Monitoring and Audit
On-site monitoring of the quality and consistency of data collection was conducted at each institution. Central monitoring of data collection was also conducted. An audit was conducted at 2 representative institutions.
RESULTS

Patients
The consort diagram is shown in Figure 1 . In total, 213 lesions from 162 cases (including patients registered twice for bilateral lesions) were primarily registered. Two patients with 3 lesions were excluded from the study, because the resections in these patients were canceled because of other concurrent lesions found after registration in 1 patient and a socioeconomic reason in the other patient; thus, 210 lesions in 160 patients underwent secondary registration. One patient did not undergo bronchoscopic marking because the patient requested postponement of the operation. The remaining 159 cases (155 patients) underwent further evaluation. Of these 155 patients, surgery was canceled in 3 patients with 4 lesions. In 2 of the patients for whom surgery was canceled, 2 lesions (1 in each patient) were found to have shrunk on postmapping CT and were clinically diagnosed as inflammatory change rather than malignant tumors; 1 of these 2 patients had another lesion also targeted by VAL-MAP and underwent surgery for this lesion as planned. The other patient with 2 lesions for whom surgery was canceled had cold-like symptoms, which exacerbated after bronchoscopy; thus, surgery was canceled, and this patient was then re-registered and underwent VAL-MAP and surgery after recovery. The remaining 157 patients underwent surgery as planned. However, because of unexpected intraoperative findings in 2 patients (pleural dissemination and fragility of tissue necessitating conversion from segmentectomy to wedge resection), unplanned resection was performed, and they were excluded from further analysis. Thus, planned resection was eventually performed for 203 lesions in 155 patients who were included for further analysis. The patient demographics of the full analysis set are shown in Table 1 . The characteristics of targeted lesions are shown in Table 2 . Among the 209 lesions, 121 (57.9%) were less than 1 cm in diameter, 109 (52.2%) were more than 1 cm in depth, and 59 (28.2%) were less than 1 cm in diameter and more than 1 cm in depth.
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Primary End Point
Among the 203 lesions in 153 patients who were eventually evaluated, 178 lesions met the criteria of successful resection (87.7%; 95% CI, 82.4-91.9). Resection failure occurred in 12.3% (25/203 lesions). There were 131 patients in whom all lesions met the criteria for successful resection, and 136 patients had successful resection of at least 1 lesion. The most common reason for failure was insufficient surgical margins (19 lesions, 76%), followed by changed operation plan due to insufficient lesion identification or insufficient marking (eg, change from wedge resection to segmentectomy: 12 lesions, 48%), changed approach due to insufficient lesion identification or insufficient marking (eg, change Registered lesions 209 FIGURE 1. Consort diagram. *Some patients were registered twice, and these cases counted as 2 cases. yThe reasons for exclusion from the FAS were deviation from the inclusion criteria, deviation from the exclusion criteria, no efficacy evaluation conducted after bronchoscopic marking, and other. zIn 1 patient, 1 lesion was not resected, and the other was resected.
from video-assisted thoracic surgery to minithoracotomy: 2 lesions, 8%), and resection not confirmed (4 lesions, 16%). In some cases, resection failure was due to multiple reasons. The success rate of resection varied among centers, ranging from 25% to 100% (Table E2) . Among centers that registered more than 10 lesions, the success rate varied from 69.2% to 95.2%. Success rate was also examined in different patient groups, according to smoking history, time from marking to operation, and lesion characteristics ( Table 3 ). The result of multivariable analysis is shown in Table 4 . The most significant factor leading to resection failure was the depth of the required resection line (P ¼ .0072). Measurement of resection margin performed occasionally or no routine measurement showed a higher risk compared with measurement on a regular basis in the center (P ¼ .044). Resection success was not associated with operation plan (wedge resection or segmentectomy), Brinkman index, or surgeons' experience. An ad hoc analysis of the study demonstrated that the risk of resection failure (ie, insufficient resection margins) increased according to the depth of the resection line, reaching 10% when the resection line was deeper than 30 mm from the lung surface (Figure 2 ).
Secondary End Point: Effectiveness of Marking
Among 559 marks made, 521 marks were successfully identified intraoperatively (93.2%; 95% CI, 90.8-95.1). The grading (intensity) of the marking is shown in (Table E4) . A previous study suggested that a Brinkman index of 500 or greater is associated with invisibility of markings 22 ; however, this relationship was not seen in the present study (marking success: Brinkman index <500, 92.8%; Brinkman index !500, 93.8%). VAL-MAP markings successfully aided in the identification of 190 lesions (93.6%; 95% CI, 89.3-96.5). Resection of the lesion (regardless of additional resection or changes in surgical plan) was achieved in 199 lesions (98.0%; 95% CI, 95.0-99.5).
Secondary End Point: Effectiveness of Marking Assisted Surgery
Regarding surgical approach, completely thoracoscopic surgery was performed in 86.0% of cases, followed by minithoracotomy with the aid of thoracoscopy (11.5%) and open thoracotomy (2.5%). The data on planned and actual approach are summarized in Table E5 . Regarding changes in surgical approach, conversion from completely thoracoscopic surgery to minithoracotomy or open thoracotomy was needed in 1.4% and 0.7% of cases, respectively, and minithoracotomy was converted to open thoracotomy in 5.9% of cases. Otherwise, the planned approach was accomplished. Regarding resection method, there were 184 resections conducted, most commonly via wedge resection (63.6%), segmentectomy (27.2%), and wedge resection followed by lobectomy (4.3%). The details and success ratio depending on resection type are shown in Table E6 . There was no obvious difference in the incidence of successful resection between wedge resection and segmentectomy.
In patients in whom only 1 resection was conducted, the average times for wedge resection and segmentectomy were 93.2 AE 57.6 minutes and 202.4 AE 63.2 minutes, respectively. The contribution of VAL-MAP to surgery as evaluated by each surgeon per case was most commonly graded as ''impossible to achieve accurate resection without mapping'' in 85 cases (54.1%), followed by ''possible to achieve the same operation but mapping enabled confident resection'' in 70 cases (44.6%). Details of the perceived contribution of VAL-MAP to surgery are shown in Table E7 .
Secondary End Point: Safety
Safety was evaluated in 155 patients who underwent bronchoscopic marking. During the study period from mapping to postoperative day 30, adverse events regardless of the association with VAL-MAP were observed in 50 patients (32.3%). The number of adverse events was 12 (7.7%) during the bronchoscopic procedure, 32 (20.6%) during postmapping CT, 5 (3.2%) in the period from mapping to surgery, and 13 (8.4%) postoperatively. The only major adverse event reported was postoperative delayed pleural fistula that necessitated readmission of the patient, although this event was judged as not associated with the VAL-MAP procedure. No patient death was reported. All reported adverse events are listed in Table E8 .
Adverse events reported in more than 1% of cases were as follows. Events observed during bronchoscopy: hypertension (3.2%), arrhythmia (1.3%), and airway bleeding (1.3%). Events observed during postmapping CT: bulla formation in the lung (10.3%), pneumothorax (10.3%; 1 patient (0.6%) needed chest tube drainage), and mediastinal emphysema (2.6%). Events observed during the period from mapping to surgery: fever higher than 38 C (1.9%). Events observed during the postoperative period: pleural fistula (1.9%) and others (3.9%). No major adverse event was directly associated with VAL-MAP.
Past or present history of bronchial asthma was seen in 14 patients (9.6%). One patient developed a cough that necessitated interruption of the procedure during bronchoscopy, and 1 patient experienced an asthma attack after surgery. Otherwise, there was no trend of adverse events in patients with versus without asthma.
DISCUSSION
Previous multicenter research has revealed that VAL-MAP is safe, whereas conventional CT-guided percutaneous needle-mediated marking results in potentially fatal air embolism in 1% to 2%. [4] [5] [6] [7] Therefore, it was not ethically acceptable to conduct the present study as a controlled study. Moreover, although a previous multicenter study demonstrated a high successful resection rate of targeted lesions (99.0%), 10 the study did not evaluate resection margins. The management of patients with positive resection margins remains an important controversial issue, 23 and even if the resection margins are negative, an insufficient resection margin distance has been demonstrated to affect local recurrence and patient survival.
14,15,24 Therefore, we set the primary end point of the present study as the successful resection rate, which was defined by the achievement of sufficient resection margins.
We set the primary goal of the study as achieving successful resection in 95% of cases, with a lower CI of 90%. However, the eventual successful resection rate was 87.5%. We consider that this result does not necessarily demonstrate ineffectiveness of the present VAL-MAP technique. Rather, we consider that it revealed an important limitation in applying the technique to a subgroup of targeted lesions and indicates a future research direction.
Multivariable analysis demonstrated that the depth of the resection line required to obtain a sufficient resection margin was the most significant factor affecting the success of resection (Table 4) . Because of the nature of the lung marking placed on the lung surface, including VAL-MAP, this limitation had been theoretically predicted. 8 Conversely, by making the resection large enough, particularly in wedge resection, this limitation was considered to be conquerable to some extent according to the surgeon's experience, thoughtful mapping design, and surgical strategy. 8, 11, 12 Moreover, the application of segmentectomy is considered to eliminate the problem. The present study clarified that the deep resection margin needs even more careful determination, even in segmentectomy in which a fan-shaped resection results in shorter resection margins for a deeply located lesion. In particular, if the required depth of resection was more than 30 mm, the risk of resection failure was greater than 10% ( Figure 2 ). Although the data are based on our single study and validation is yet to be done, this result indicates that such cases require special attention or reconsideration of the surgical plan. We are developing improvements in the VAL-MAP technique by not limiting it to the lung surface, but extending it to deeper regions (ie, 3-dimensional mapping). We are initiating a clinical trial combining the current VAL-MAP technique with bronchoscopic coil marking to indicate the deep resection line. The VAL-MAP technique is still being developed, and the present study played a critical role in revealing the current limitation and an important future direction.
It was challenging to set an appropriate goal in the present single-arm study. The goal of the present study was set on the basis of previous internal data of VAL-MAP in a single institution and histologic data of conventional CT-guided marking in the same institution, both of which could have been biased. Because data on resection margins were not collected in the previous multicenter study, 10 we used data from an institution where the data on resection margins were routinely collected. Although the data showed successful resection in 47 of 49 lesions by the definition of success in the present study (95.8%), we did not take center-to-center variation into consideration. Indeed, the outcome of the present study showed high variance among centers (Table E2 ). It is possible that the present results were biased by the large number of centers and operators involved, with a relatively low number of included patients. Moreover, among participating centers where the resection margins had been routinely measured, the successful resection rate reached 94.1%, suggesting that this was a significant factor affecting successful resection (Table 4) . Therefore, the hands-on practice used by surgeons to measure resection margins may be surprisingly important for successful resection, although the importance of resection margins has been generally recognized by most surgeons. The historical data of CT-guided marking also may have been biased. We estimated a maximum success rate of 85% in the historical control, assuming that all the cases with incomplete descriptions of resection margins were successful. Although the actual success rate among cases with full descriptions of resection margins was only 67%, we considered the possibility that resection margins tended to be reported when the resection margin was insufficient. Once again, for ethical and safety reasons, a direct comparison between the 2 marking methods was avoided in the present study, which was a limitation of this prospective study. Because safety was a concern with conventional CT-guided marking and indeed motivated us to develop the VAL-MAP method, 3, 8 the present study reinforced the evidence on the safety of VAL-MAP as a secondary end point that was demonstrated in a previous multicenter study. 10 Notably, the other secondary end points of effectiveness of marking, effectiveness of marking-assisted surgery, and safety demonstrated satisfactory outcomes. This suggests that the VAL-MAP technique was appropriately conducted in centers in most cases, whereas many cases of resection failure occurred despite the success of lung mapping. Therefore, together with the outcome of a previous study, 10 the current VAL-MAP technique is considered to be well established and well reproducible in various centers. However, it is important for surgeons to pay careful attention to resection margins, even with VAL-MAP, and the current VAL-MAP technique needs further improvement when targeting a lesion that necessitates a deep resection line.
The present study did not investigate the long-term outcome of patients who underwent sublobar lung resection. Insufficient resection margins reportedly lead to frequent local recurrence [13] [14] [15] [16] and poorer clinical outcomes. 17 The present study allowed for additional resection or changes in operation plan if surgeons thought that the resection margin was insufficient; taking this into consideration, an ultimately successful resection with satisfactory margins was achieved in 98.0%. Evaluation of such long-term end points will reveal the eventual clinical usefulness of the technique. Notably, the current VAL-MAP technique necessitates an additional bronchoscopic procedure and CT scan, which adds an extra cost on top of the cost of surgery. Thus, a cost-benefit analysis of the use of VAL-MAP should be performed.
CONCLUSIONS
The present study demonstrated the reasonable efficacy and high safety of VAL-MAP. The depth of the required margin was the most significant factor leading to resection failure when using the present VAL-MAP technique. Further investigation is undergoing to overcome this challenge.
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Discussion
Dr Y. Colson (Boston, Mass). The only disclosure that I have is an equipment loan for a camera from Novadaq, but otherwise, none.
As you have highlighted, this intraoperative localization of these small pulmonary nodules is an important challenge, and I know in the United States with lung cancer screening we are thinking it's approximately 1.5 to 2 million people. I assume it's similar in Japan in terms of incidence. As you have highlighted, those that are nonpalpable or located deep are challenging, and you have shown that in your study.
There are a variety of different ways people are talking about actually localizing these nodules. Some are actually using physical markers, some use dye, some are using molecular markers, and others are doing more adjunct imaging modalities. They all have risks and benefits, and I think you have shown that yours is safe and low risk, and has minimal potential for side effects. However, the ideal localization has to be both technically and logistically feasible and add value to the care of the patients. Given this, there are several questions.
Right upper lobe lesions, for example, can be technically challenging to reach by a navigational bronchoscopy approach to put your dye in. Is that a challenge for you on the VAL-MAP in certain locations, especially to get multiple areas of marking? If so, how many of the patients had tumors in those locations? Were you able to reach them or were they excluded because they weren't considered to be appropriate for the study?
Dr Masaaki Sato (Tokyo, Japan). Sorry, I didn't quite understand the question. Dr Colson. The difficulty in reaching specific lesions, for example, the right upper lobe can be hard to get the catheter all the way up and administer dye in multiple locations, or do you not have any challenging locations for tumors with VAL-MAP? Dr Sato. In terms of the locations, basically we do not have any challenge. You can even put the dye on, for example, the diaphragmatic side or mediastinal side. Of course, the number TABLE E1. Inclusion and exclusion criteria. Patients meeting inclusion criteria I to III and not meeting the exclusion criteria completed primary registration after the provision of informed consent. Secondary registration was completed after approval by the case review committee and confirmation that each patient met all the inclusion criteria I. A case in which pulmonary malignancy was suspected or diagnosed and the establishment of resection lines other than the typical interlobar fissure were required. II. A case that required careful determination of resection lines to ensure resection margins because of difficult intraoperative tumor localization due to any of the following: A) Lesions that were difficult to identify intraoperatively because of the characteristics of the lesion, including i) lesions containing GGO in whole or in part; ii) lesions with a tumor diameter of 5 mm; iii) lesions whose distance from the visceral pleura was larger than the tumor diameter. B) Lesions that were difficult to identify intraoperatively because of underlying lung conditions: i) Severe pleural adhesion was expected (eg, past history of open chest surgery); ii) Preexisting benign nodules that were confusing and misleading (eg, silicosis, previous tuberculosis); C) Lesions/conditions judged to require marking for other reasons (state the reasons for marking requirement). III. The consent of the patient or substitute had been obtained. IV. At the time of secondary registration, !2 certified thoracic surgeons agreed that lung marking was necessary for resection.
Exclusion criteria: I. Allergy to indigo carmine II. Pregnancy III. Bronchoscopy or marking could not be conducted because of existing complications. IV. Other reasons that were considered by the corresponding or participating surgeons/physicians to render the patient inappropriate for inclusion in the study.
GGO, Ground-glass opacity. *Others indicates cases in which there were unexpected unusual changes in the surgical plan. In 1 patient, unexpected dissemination was found intraoperatively, and a wedge resection of the suspected dissemination was conducted instead of the planned operation. In the other patient, the markings were not clearly visible, and the planned wedge resection was not conducted (counted as a failure).
1701. Impossible to achieve accurate resection without mapping 12 27.9 Possible to achieve the same operation but mapping enabled confident resection 29 67.4 Mapping was not necessary to achieve the same accuracy of operation 2 4.7 Cavity (N ¼ 3)
Impossible to achieve accurate resection without mapping 2 66.7 Possible to achieve the same operation but mapping enabled confident resection 1 33.3 Mapping was not necessary to achieve the same accuracy of operation 0 0.0 Diameter of the lesion <20 mm (N ¼ 113) Impossible to achieve accurate resection without mapping 57 50.4 Possible to achieve the same operation but mapping enabled confident resection 54 47.8 Mapping was not necessary to achieve the same accuracy of operation 2 1.8 !20 mm (N ¼ 14)
Impossible to achieve accurate resection without mapping 6 42.9 Possible to achieve the same operation but mapping enabled confident resection 8 57.1 Mapping was not necessary to achieve the same accuracy of operation 0 0.0 Depth of the lesion <20 mm (N ¼ 110) Impossible to achieve accurate resection without mapping 58 52.7 Possible to achieve the same operation, but mapping enabled confident resection 50 45.5 Mapping was not necessary to achieve the same accuracy of operation 2 1.8 !20 mm (N ¼ 17)
Impossible to achieve accurate resection without mapping 5 29.4 Possible to achieve the same operation but mapping enabled confident resection 12 70.6 Mapping was not necessary to achieve the same accuracy of operation 0 0.0 CT, Computed tomography; GGO, ground-glass opacity.
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